Appendix Table 3.
LCD score and prevalence and amount of CAC at baseline among non-diabetic participants (Cross-sectional)
| CAC prevalence (N=2,335) at baseline (N=4,986) | Baseline CAC amount in those with CAC>0 at baseline (N=2,335) | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Prevalence ratio | 95% CI* | Regression coefficient | SE* | |||
|
| ||||||
| Overall LCD score | ||||||
| Q1 | - | - | ||||
| Q2 | 1.05 | 0.98, 1.12 | 10.9 | 8.9 | ||
| Q3 | 1.01 | 0.94, 1.09 | 10.9 | 9.3 | ||
| Q4 | 1.02 | 0.95, 1.10 | 1.0 | 9.9 | ||
| Q5 | 1.01 | 0.93, 1.10 | −9.7 | 10.7 | ||
| P for linear trend | 0.91 | 0.44 | ||||
| Animal-based LCD score | ||||||
| Q1 | - | - | ||||
| Q2 | 1.02 | 0.96, 1.09 | 13.3 | 8.8 | ||
| Q3 | 0.98 | 0.91, 1.05 | −0.7 | 9.4 | ||
| Q4 | 0.98 | 0.91, 1.05 | −15.4 | 9.9 | ||
| Q5 | 1.00 | 0.93, 1.08 | −5.0 | 9.9 | ||
| P for linear trend | 0.45 | 0.22 | ||||
| Plant-based LCD score | ||||||
| Q1 | - | - | ||||
| Q2 | 1.02 | 0.95, 1.09 | 5.3 | 9.3 | ||
| Q3 | 1.02 | 0.95, 1.09 | −2.0 | 9.4 | ||
| Q4 | 0.99 | 0.92, 1.06 | −5.2 | 9.4 | ||
| Q5 | 1.03 | 0.95, 1.11 | −18.3 | 10.9 | ||
| P for linear trend | 0.91 | 0.08 | ||||
LCD, low-carbohydrate-diet; CAC, coronary artery calcium; CI, confidence interval; SE, standard error; Q, quintile.
*
Adjusted for age, gender, race, educational level, body mass index, physical activity, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, total energy intake, alcohol use, tobacco use, and history of hypertension at baseline